IDP 113Alternative Names: IDP-113
Latest Information Update: 04 Aug 2015
At a glance
- Originator Dow Pharmaceutical Sciences
- Class Antifungals; Small molecules; Triazoles
- Mechanism of Action 14-alpha demethylase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Tinea capitis
Most Recent Events
- 30 Aug 2010 Phase II development is ongoing in USA